We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$8.17B
1-Year Est. Return
68.82%
This Fund
S&P 500
This Quarter
Est. Return
+1.37%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$5.76B
AUM Growth
+$32.7M
(+0.57%)
Cap. Flow
+$188M
Cap. Flow
% of AUM
3.27%
Top 10 Holdings %
Top 10 Hldgs %
50.49%
Holding
248
New
70
Increased
46
Reduced
39
Closed
50
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$136M |
| 2 |
Freshpet
FRPT
|
+$91.3M |
| 3 |
Ross Stores
ROST
|
+$81.3M |
| 4 |
Five Below
FIVE
|
+$72.6M |
| 5 |
EXAS
Exact Sciences
EXAS
|
+$64.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$75.6M |
| 2 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$71.5M |
| 3 |
Illumina
ILMN
|
+$62.5M |
| 4 |
AstraZeneca
AZN
|
+$55.2M |
| 5 |
Tractor Supply
TSCO
|
+$51.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.48% |
| 2 | Miscellaneous | 31.17% |
| 3 | Consumer Discretionary | 9.47% |
| 4 | Consumer Staples | 8.21% |
| 5 | Technology | 4.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Biohaven
BHVN
$2.27B
| $9.02M | 0.16% |
+1,464,936
| New | +$10.6M |
|
|
AMYT
77
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
| $8.8M | 0.15% |
1,272,000
+94,000
| +8% | +$701K |
|
78
Meta Platforms (Facebook)
META
$1.56T
| $8.28M | 0.14% |
61,000
-14,000
| -19% | -$2.27M |
|
79
Insulet
PODD
$9.87B
| $8.26M | 0.14% |
+36,000
| New | +$9.02M |
|
80
Aterian
ATER
$12.3M
| $8.01M | 0.14% |
+538,500
| New | +$15.7M |
|
81
CrowdStrike
CRWD
$214B
| $7.91M | 0.14% |
192,000
+24,000
| +14% | +$1.1M |
|
82
Advanced Micro Devices
AMD
$827B
| $7.6M | 0.13% |
120,000
+12,000
| +11% | +$1.02M |
|
|
TARO
83
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $7.36M | 0.13% |
245,372
+81,372
| +50% | +$2.81M |
|
|
SPPI
84
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $7.17M | 0.12% |
16,676,000
-424,000
| -2% | -$417K |
|
|
NBP
85
NovaBridge Biosciences American Depositary Shares
NBP
$208M
| $7.09M | 0.12% |
1,768,000
-1,556,000
| -47% | -$11.8M |
|
86
Swvl Holdings
SWVL
$121M
| $6.99M | 0.12% |
+332,160
| New | +$17.3M |
|
87
Intuit
INTU
$86.8B
| $6.58M | 0.11% |
+17,000
| New | +$7.34M |
|
88
ServiceNow
NOW
$138B
| $6.42M | 0.11% |
85,000
+17,500
| +26% | +$1.58M |
|
|
ZIMV
89
DELISTED
ZimVie
ZIMV
| $6.42M | 0.11% |
+650,000
| New | +$10.5M |
|
90
Booking.com
BKNG
$135B
| $6.08M | 0.11% |
92,500
+12,500
| +16% | +$939K |
|
|
PIXY
91
DELISTED
ShiftPixy, Inc. Common Stock
PIXY
| $5.75M | 0.1% |
+1,157
| New | +$9.05M |
|
92
Aurinia Pharmaceuticals
AUPH
$2.15B
| $5.44M | 0.09% |
+724,000
| New | +$6.27M |
|
93
MongoDB
MDB
$28.7B
| $5.36M | 0.09% |
+27,000
| New | +$7.88M |
|
94
Workday
WDAY
$44.8B
| $5.33M | 0.09% |
+35,000
| New | +$5.48M |
|
|
CMRX
95
DELISTED
Chimerix, Inc.
CMRX
| $5.32M | 0.09% |
2,756,000
-768,000
| -22% | -$1.72M |
|
96
Netflix
NFLX
$319B
| $5.3M | 0.09% |
225,000
-275,000
| -55% | -$6.11M |
|
|
BGXX
97
DELISTED
Bright Green Corporation Common Stock
BGXX
| $5.14M | 0.09% |
+4,761,905
| New | +$7.36M |
|
98
Advantage Solutions
ADV
$398M
| $5.11M | 0.09% |
96,000
-5,440
| -5% | -$502K |
|
99
Bath & Body Works
BBWI
$3.79B
| $5.05M | 0.09% |
+155,000
| New | +$5.47M |
|
|
SKX
100
DELISTED
Skechers
SKX
| $4.65M | 0.08% |
146,616
-39,770
| -21% | -$1.49M |
|
Similar funds
MWM
BP
FWCM
SC
SFM
EHC
BIM
WF
Armistice Capital's Q3 2022 Portfolio in Review
As of Q3 2022, Armistice Capital held 248 positions worth $5.76B, up 0.57% from $5.73B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Armistice Capital deployed $188M of net new capital in Q3 2022, opening 70 new positions and adding to 46 existing holdings. Its largest new stake was GSK: 3,600,000 shares worth $106M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $46.6M trimmed.
- Armistice Capital's largest Q3 2022 buy was GSK: 3,600,000 shares worth $106M.
- Armistice Capital added most to Freshpet in Q3 2022, an estimated $91.3M increase.
- Armistice Capital's biggest Q3 2022 reduction was Vertex Pharmaceuticals, cutting an estimated $46.6M.
- Armistice Capital fully exited Dollar General in Q3 2022, selling an estimated $75.6M.
- Armistice Capital's ten largest holdings make up 50% of its $5.76B portfolio in Q3 2022.
- Armistice Capital opened 70 new positions and closed 50 in Q3 2022.
- Armistice Capital's portfolio value rose 0.57% quarter-over-quarter to $5.76B.
Based on Armistice Capital's 13F filing for Q3 2022, filed 14 Nov 2022.